Methyl 4-(4-Chloro-6-methyl-2-pyrimidinyl)-1-methoxycyclohexanecarboxylate may be useful in the preparation of heterocyclyl aminopyrazoles as inhibitors of RET kinase for treatment of cancer.
参考文献
Brubaker, J. D., et al.: U.S. Pat. Appl. Publ., 48 pp., US 20170121312 (2017)
沪ICP备17019645号
400-821-0725
